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Introduction: Current practice guidelines emphasize the importance of rapid reperfusion of patients with ST-elevation myocardial infarction (STEMI). The aim of this
study was to evaluate the current rate of compliance with evidence-based practice guidelines for the management of STEMI patients at a tertiary hospital in Kenya.
Methods: This was a retrospective chart review. Data on patient characteristics, emergency treatment, and outcomes were collected on adults admitted with a diagnosis
of STEMI from January 2012 to February 2013.
Results: Data were collected for 45 patient presentations. There were 37 male patients (82%). The mean age was 59.7 ± 3.8 years. Of the 45 patients, 23 were Asian
(51%), 18 were Black (40%) and four were Caucasian (9%). Thirty-ﬁve patients (78%) presented within 12 h of symptom onset. Within 10 min of arrival to the hos-
pital, 40 patients (89%) had electrocardiographs performed and 39 patients (87%) were reviewed by a doctor. Medications given on presentation were aspirin (98%),
clopidogrel (91%) and anticoagulants (73%). All patients received reperfusion therapy. Twenty-eight patients (62%) received ﬁbrinolytic therapy and 17 patients (38%)
had primary percutaneous coronary intervention. Door-to-needle time of <30 min was achieved in 43% of the cases. Door-to- balloon time was <90 min in 29% of
the cases. All the patients survived to hospital discharge. The average length of stay was 5.3 ± 1.0 days. In-hospital complications occurred in six patients (13.3%).
These included bleeding (three patients), stroke (one patient) and cardiogenic shock requiring intra- aortic balloon pump support (two patients).
Conclusion: Whereas the majority of STEMI patients are evaluated within 10 min of presentation, less than 50% receive reperfusion therapy within the recommended
time frame. While there are attempts to comply with evidence based guidelines in resource-limited settings, there is a need to improve acute care systems to target early
reperfusion of STEMI patients.Introduction: Les directives pratiques actuelles mettent l’accent sur la reperfusion rapide des patients victimes d’un infarctus du myocarde avec e´le´vation du segment ST
(STEMI). L’objectif de cette e´tude e´tait d’e´valuer le taux de conformite´ actuel aux directives pratiques scientiﬁquement fonde´es pour la prise en charge des patients
victimes de STEMI dans un hoˆpital tertiaire au Kenya.
Me´thodes: Cette e´tude a consiste´ en un examen re´trospectif des dossiers. Les donne´es relatives aux caracte´ristiques des patients, au traitement d’urgence et aux re´sultats
ont e´te´ recueillies pour des adultes admis avec un diagnostic de STEMI entre janvier 2012 et fe´vrier 2013.
Re´sultats: Des donne´es ont e´te´ recueillies pour 45 cas. Trente-sept e´taient des hommes (82%). L’aˆge moyen e´tait de 59,7 ± 3,8 ans. Sur les 45 patients, 23 e´taient
asiatiques (51%), 18 e´taient noirs (40%) et quatre caucasiens (9 %). Trente-cinq patients (78%) s’e´taient pre´sente´s dans les 12 heures suivant l’apparition des symptoˆ-
mes. Dans les dix minutes suivant leur arrive´e a` l’hoˆpital, 40 patients (89%) passaient un e´lectrocardiogramme et 39 patients (87%) e´taient examine´s par un me´decin.
Les me´dicaments administre´s a` l’arrive´e e´taient les suivants : aspirine (98%), clopidogrel (91%) et anticoagulants (73%). Tous les patients ont be´ne´ﬁcie´ d’un traitement
de reperfusion. Vingt-huit patients (62%) s’e´taient vu administrer une the´rapie ﬁbrinolytique et 17 patients (38%) avaient subi une angioplastie coronarienne percutane´e
primaire. Un de´lai d’attente infe´rieur a` 30 min e´tait enregistre´ dans 43% des cas. Un de´lai de traitement infe´rieur a` 90 min e´tait enregistre´ dans 29% des cas. Tous les
patients survivaient jusqu’a` leur sortie de l’hoˆpital. La dure´e moyenne du se´jour e´tait de 5,3 ± 1 jour. Six patients (13,3%) ont souffert de complications pendant leur
se´jour. Ces complications e´taient les suivantes : saignements (trois patients), attaque (un patient) et collapsus cardiaque ne´cessitant une assistance par pompe a` ballon-
net intra-aortique (deux patients).
Conclusion: Alors que la majorite´ des patients souffrant de STEMI e´taient examine´s dans les dix minutes suivant leur arrive´e, moins de 50% be´ne´ﬁciaient d’une the´ra-
pie de reperfusion dans le de´lai recommande´. Si l’on peut constater des tentatives de se conformer aux directives scientiﬁquement fonde´es dans des milieux caracte´rise´s
par une insufﬁsance de ressources, il est ne´cessaire d’ame´liorer les syste`mes de prise en charge active aﬁn de cibler la reperfusion pre´coce des patients victimes de STEMI.African relevance
 Cardiovascular disease is the second commonest cause of
death in Africa.
 African clinicians are able to comply with evidence-based
practice guidelines.
 African clinicians can strengthen cardiovascular services in
acute care systems.
Table 1 Age distribution of patients.
Age Number of patients (n= 45)
<55 years 16
55–64 years 14
65–74 years 8
P75 years 7
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Evidence-based practice guidelines specify a maximum delay
of 30 min for ﬁbrinolysis and 90 min for primary percutaneous
coronary intervention (PCI) for patients with ST-elevation
myocardial infarction (STEMI).1 These guidelines derive
almost exclusively from the developed world populations,
and whether these guidelines are applicable to population
groups outside the developed world is unknown.2–5
The observed delays for primary PCI in STEMI registries
mainly from the developed world often largely exceed those
realised in clinical trials.6–8 A signiﬁcant number of patients
do not receive either ﬁbrinolysis or primary PCI within these
recommended maximum delays. The ACCESS (Acute Coro-
nary Events – a Multinational Survey of Current Manage-
ment Strategies) registry is the only registry that has tried
to gain insights into the epidemiology, practice patterns,
and outcomes of STEMI patients among different population
groups in underdeveloped nations.9 The study was conducted
in countries in Africa, Latin America, and the Middle East.
ACCESS data from South Africa showed that the use of
evidence-based interventions was in-line with practices in
the developed world though there was still room for improve-
ment.10 A prospective study done here in Kenya at the Aga
Khan University Hospital, Nairobi (AKUH,N) in 2010,
showed that no reperfusion therapy was given to one-third
of all STEMI patients due to late presentation to the
hospital.11 There were low rates of primary PCI and door-
to-balloon times were prolonged, with the majority of the
eligible patients receiving ﬁbrinolysis.
The aim of this study was to evaluate the current rate of
compliance with evidence-based practice guidelines for the
management of STEMI patients at AKUH,N. The results of
the study will hopefully demonstrate the progress in the man-
agement of STEMI at AKUH,N and inform any future local
developments aimed at ensuring maximal compliance with evi-
dence-based practice guidelines. This will hopefully translate
into improved management and outcomes for STEMI patients
in Kenya.
Methods
The Republic of Kenya is located on the equator in eastern
Africa, and borders Ethiopia, Somalia, Tanzania, Uganda
and Sudan; the country’s east coast is along the Indian Ocean.
The country has a population of over 38 million people; Nai-
robi, the capital, is the largest city of Kenya, with a population
of more than three million people.12
The Aga Khan University Hospital, Nairobi (AKUH,N),
established in 1958, is a regional tertiary referral university
hospital that provides secondary and tertiary level health care
services in Nairobi, Kenya.13 It has a 24-h Emergency Centre
(EC) and primary PCI capabilities with an interventional car-
diologist on-call 24-h a day.
A retrospective chart review was conducted at AKUH,N
between 1 January 2012 and 28 February 2013 of all patients
aged P21 years admitted with a diagnosis of acute coronary
syndrome (ACS). All patients with a ﬁnal discharge diagnosis
of STEMI were included in the study.
Patients were excluded if their symptoms were precipitated
by a secondary co-morbidity (e.g., anaemia, heart failure, andnon-cardiac trauma), they were transferred in from other
hospitals having already been initially managed for STEMI
and if their emergency records were incomplete or not
found.
The study was approved by the Aga Khan University Fac-
ulty of Health Sciences East Africa research ethics committee
(2013/REC-44). Patient conﬁdentiality was maintained by se-
cure storage of data sheets, use of an anonymous coding sys-
tem and restricted access to the database.
Data sheets were used to record the information directly
from the patients’ records. Data collected on each patient in-
cluded: age, sex and ethnicity; presenting complaint; dura-
tion of symptoms; systolic blood pressure on admission;
time to initial electrocardiograph (ECG) from ﬁrst medical
contact; time to initial doctor review; medication on arrival;
door-to-needle (ﬁbrinolysis) time; door-to-balloon inﬂation
(primary PCI) time; in-hospital complications; medications
on discharge, length of stay and discharge condition. Data
were entered and analysed using Microsoft Excel 2010
software.
Results
Data were collected for 45 patient presentations, 37 of which
were male patients (82%). The mean age was 59.7 ± 3.8 years.
The age distribution of the patients is shown in Table 1. Of the
45 patients, 23 were Asian (51%), 18 were Black (40%) and
four were Caucasian (9%).
Thirty-ﬁve patients (78%) presented within 12 h of onset
of symptoms, while 19 patients (42%) presented within the
ﬁrst 2 h. The median (Q1, Q3) delay from symptom onset
to hospital admission for patients who presented within
12 h was 2.0 (1.0, 5.0) h. All the patients had a history of
chest pain on presentation. Nine patients had concurrent
shortness of breath and four had other symptoms e.g. epigas-
tric pain, nausea, and vomiting. Three patients were in car-
diac arrest at presentation. Six patients had no risk factors
for ACS. Figure 1 shows the risk factors present in the study
population. The rate of compliance with practice guidelines is
shown in Table 2.
Medications given on presentation were aspirin (98%),
clopidogrel (91%), anticoagulation (73%), nitroglycerine
spray (31%) and morphine (26%). All patients received reper-
fusion therapy. Twenty-eight patients (62%) received ﬁbrinoly-
sis with bolus tenecteplase while 17 patients (38%) had
primary PCI done. All the patients survived to hospital dis-
charge. The average length of stay in the hospital was
5.3 ± 1.0 days. The in-hospital complication rate was 13.3%
(n= 6). These included bleeding (three patients), stroke (one
patient) and cardiogenic shock requiring intra-aortic balloon
pump support (two patients).
Table 2 Rate of compliance with practice guidelines.
Guideline Compliance
rate, % (n)
Initial ECG done within 10 min of ﬁrst medical
contact
89 (40)
Initial doctor review within 10 min of arrival 87 (39)
Door-to-needle (ﬁbrinolysis) goal of 30 min 43 (12)
Door-to-balloon inﬂation (primary PCI) goal of
90 min
29 (5)
Figure 1 Risk factors for acute coronary syndrome.
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This is a study describing the proﬁle, management and out-
comes of 45 STEMI patients at AKUH,N in Kenya and the
compliance with evidence-based practice guidelines. The
majority (82%) of our patients were males which was similar
to other international registries, namely, ACCESS (81%).9
The patients in our study had a mean age of 59.7 ± 3.8 years
which may be attributed to the increasing incidence of risk fac-
tors for ACS (diabetes, hypertension, and hyperlipidaemia) in
a much younger population in our society.14
The three most common risk factors for STEMI in our pa-
tients were hypertension, diabetes and dyslipidaemia. These
risk factors were among others, including abdominal obesity,
psychosocial factors, lack of daily consumption of fruits and
vegetables, regular alcohol consumption, and lack of regular
physical activity; also identiﬁed by the worldwide INTER-
HEART study accounting for more than 90% of the popula-
tion-attributable risk of a ﬁrst myocardial infarction.15 More
programmes targeting the prevention and control of these
three risk factors in our population should be implemented
to reduce the incidence of ACS. Patients with one or more
of the risk factors for ACS should also be educated on their in-
creased risk and identiﬁcation of early warning symptoms for
ACS.
Majority of our patients (78%) presented within 12 h of
symptoms onset with 42% presenting within 2 h. Increased
educational initiatives on the importance of early presentationfor chest pain symptoms instituted by the hospital may have
contributed to this increase in patients presenting early.
Many patients with STEMI present late after the develop-
ment of symptoms. The time from symptom onset to hospital
presentation in different registries of patients has beenP 4 h
in almost 50%,16 more than 6 h in 40%,17 and more than
12 h in 9–31%.2,18 The absence of an established public pre-
hospital care system means the majority of our patients arrive
by private vehicle.19 Out-of-hospital transport time constitutes
only 5% of the delay to treatment time.20 The decision to use
an ambulance is an important variable that can reduce out-of-
hospital delay.
The interval from the onset of symptoms to the patient’s
recognition of them constitutes the majority (60–70%) of the
delay to deﬁnitive therapy.21 Public education programs have
had only transient effects.22 Education of patients with known
coronary artery disease appears to be the only effective pri-
mary intervention to reduce denial or misinterpretation of
symptoms.
Almost 90% of the patients had an ECG done and were
seen by a doctor within 10 min of arrival to the hospital. This
success is probably due to standing orders for nurses in the
hospital to obtain a 12-lead ECG on any patient with chest
pain suspected of having myocardial ischemia or acute myo-
cardial infarction. This was one of the strategies recommended
by the National Heart Attack Alert Program Coordinating
Committee to reduce some of the delays in treatment times
for acute myocardial infarction patients.23
There was a striking consistency in the hospital use of anti-
platelets with almost all patients (98%) receiving aspirin upon
presentation to the hospital. This is consistent with the rates
reported in other registries (P95%)24,25 and in keeping with
current medical practice, where the majority of patients pre-
senting with ACS are given aspirin.
There was a higher rate of ﬁbrinolysis (62%) in our study
compared with North American and European registries
(<50%).3,9 The rate of primary PCI in our study was 38%
compared to 40% in ACCESS9 and 58–64% in the second
Euro Heart Survey (EHS-ACS-II)24 and the Global Registry
of Acute Coronary Events (GRACE) study.2 This is probably
due to a combination of factors. Primary PCI has only been
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to other regions that have been doing it for a longer time
and therefore have well-established systems that ensure efﬁ-
ciency and minimize delays. After-hours primary PCI is also
a challenge due to stafﬁng availability in the catheterization
laboratory. Patients who presented shortly after symptom on-
set (within 2 h) and where the delay to primary PCI was esti-
mated to be more than 90 min from initial hospital
presentation, preferentially received ﬁbrinolysis. This practice
is based on recent studies that compared primary PCI to ﬁbri-
nolysis in patients who present within 3 h of symptom onset. In
the STREAM study which randomly assigned 1892 patients
who presented within 3 h to undergo either ﬁbrinolytic therapy
with bolus tenecteplase or primary PCI, there was no differ-
ence in the primary composite end point (death, shock, conges-
tive heart failure, or reinfarction up to 30 days) between the
two groups (12.4% versus 14.3%, respectively; relative risk
0.86, 95% CI 0.68–1.09).26 Fibrinolysis was also chosen after
hours when primary PCI was not readily available.
A door-to-needle time within the recommended 30 min was
achieved in only 43% of the patients who received thromboly-
sis. In the GUSTO trial which evaluated in-hospital delays as
part of the GUSTO Time to Treatment Substudy, less than 5%
of patients were treated within 30 min of arrival.27 Established
protocols in our EC that identify and prioritize patients pre-
senting with STEMI may have contributed to the reduced de-
lay in the door-to-needle time rates in our study. Further
improvement in the compliance with the guidelines can be
achieved through regular education and training of the EC
doctors who are responsible for initial evaluation and manage-
ment of the patient.24 The EC doctors should be proﬁcient in
the determination of eligibility of ﬁbrinolytic therapy and be
responsible for the initiation of the therapy. Determination
of ﬁbrinolytic therapy eligibility by EC doctors reduces the de-
lay in ﬁbrinolytic therapy initiation by approximately 50%.28
For patients who have typical and uncomplicated presenta-
tions of STEMI, requiring communication with the internist
or cardiologist before initiating ﬁbrinolytic therapy is inappro-
priate and may result in unnecessary delays trying to locate
these consultants.
Thirty-eight percent of our patients had primary PCI com-
pared to 13% in the previous study.11 Only 29% of these cases
achieved a door-to-balloon time (DTBT) of less than 90 min.
Similar rates have been observed in other studies. The DTBT
in the United States has been decreasing slowly. In large sur-
veys, the median DTBT fell from 120 min from 1994 to 1995
to 108 min from 1999 to 2002;29,30 however, between 1999
and 2002, only 35% of patients met the recommended goal
of less than 90 min.30 Evidence for a detrimental effect of long-
er DTBTs on outcomes comes from both observational studies
and randomized trials. In a report of 29,222 STEMI patients in
the NRMI-3 and 4 registries (1999–2002) who were treated
with PCI within 6 h of presentation, longer DTBTs were
signiﬁcantly associated with increased in-hospital mortality
(3.0, 4.2, 5.7, and 7.4% for DTBT of 690 min, 91–120 min,
121–150 min, and >150 min, respectively).31 Patients with
DTBTs more than 90 min had a higher mortality compared
to those with DTBTs 690 min (odds ratio 1.42, after adjusting
for patient characteristics). In a multivariate analysis of 365
hospitals, seven strategies that reduced DTBT were identiﬁed:
activation of the catheterization laboratory by the EC physi-
cian (mean reduction in DTBT, 8.2 min), single call activationof the catheterization laboratory (13.8 min), staff arrival in the
catheterization laboratory within 20 min compared to more
than 30 min after being paged (19.3 min), having a cardiologist
always on site (14.6 min), having EC and the catheterization
laboratory staff use real-time feedback (8.6 min), EC
activation of the catheterization laboratory while the patient
is en-route (15.4 min), regular audits of performance times
and standard and simple algorithms.32 Regular audits of
performance times and standard and simple algorithms have
already been implemented in the hospital in a bid to reduce
the DTBT.
An earlier time to presentation of our STEMI patients and
potentially the presence of a well-established system for their
management may have contributed to our 0% mortality rate.
Although our study sought to provide a representative sam-
ple of patients with STEMI from everyday practice, it was a
retrospective chart review that was subject to limitations and
biases, including incomplete information; collection of nonran-
domized data; as this was one hospital, the population may not
be representative of the whole country. Eligible patients were
those who were alive at hospital admission, meaning that the
highest risk patients (i.e., those who died before reaching the
hospital) were excluded.Conclusion
This study highlights a number of important features in the
acute management of STEMI patients in our setting that has
implications for the development of acute care systems in Ken-
ya. Whereas the majority of STEMI patients are evaluated
within 10 min of presentation, less than 50% receive reperfu-
sion therapy within the recommended time frame. While there
are attempts to comply with evidence-based guidelines in re-
source-limited settings, there is a need to strengthen acute care
systems to target early reperfusion of STEMI patients.
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